Related content

An open-label, dose-escalation, safety, and pharmacokinetics phase I study of ombrabulin, a vascular disrupting agent, administered as a 30-min intravenous infusion every 3 weeks in Japanese patients with advanced solid tumors

By Murakami H.   Kurata T.   Onozawa Y.   Watanabe J.   Ono A.   Takahashi T.   Yamamoto N.   Fujisaka Y.   Kiyota H.   Hayashi H.   Tanaka K.   Nakagawa K.   Kuroda S.  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 623-630

Springer Publishing Company

Access to resources Recommend Favorite

Phase II, open-label trial to assess QTcF effects, pharmacokinetics and antitumor activity of afatinib in patients with relapsed or refractory solid tumors

By Molife L.   Rudman Sarah   Alam Salma   Tan Daniel   Kristeleit Hartmut   Middleton Gary   Propper David   Bent Liz   Stopfer Peter   Uttenreuther-Fischer Martina   Wallenstein Gudrun   de Bono Johann   Spicer James  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1213-1222

Springer Publishing Company

Access to resources Recommend Favorite

Randomized, open label, prospective study on the effect of zoledronic acid on the prevention of bone metastases in patients with recurrent solid tumors that did not present with bone metastases at baseline

By Mystakidou Kyriaki   Katsouda Emmanuela   Parpa Efi   Kelekis Alexis   Galanos Antonis   Vlahos Lambros  

Medical Oncology, Vol. 22, Iss. 2, 2005-06 ,pp. : 195-201

Humana Press, Inc

Access to resources Recommend Favorite

A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors

By Yan Zhao   Zhu Zhongling   Li Kai   Chen Peng   Wang Liuchun   Huang Chun   Xue Jinhuai   Liu Meijun  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 955-961

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumours

By Androulakis N.   Kouroussis C.   Mavroudis D.   Kakolyris S.   Souglakos J.   Agelaki S.   Kalbakis K.   Malas K.   Pallis A.   Samonis G.   Georgoulias V.  

European Journal of Cancer, Vol. 38, Iss. 15, 2002-10 ,pp. : 1992-1997

Elsevier

Access to resources Recommend Favorite